We sit down to interview Peter Marks, Director of the Center for Biologics Evaluation and Research at the US FDA.

Global regulators attended a virtual workshop on second generation COVID-19 vaccines – here’s what they talked about.

Bringing customized medicines to patients with additive manufacturing.

How can pharma make the most of digital technologies?

Find out how a random act of kindness set Antoinette Gawin on the path to becoming a VP in her twenties.

GSK forms strategic partnership with Alector to produce monoclonal antibodies for neurodegenerative diseases.

Can a new malaria vaccine hold the key to reliable, durable protection?

Edd Stone of TTP explains how the industry is overcoming the manufacturing challenges associated with cell therapies.

GlaxoSmithKline’s Senior Vice President of US Oncology speaks about the pandemic and its impact on patients.

What role can regulators play in overcoming the barriers to the adoption of continuous manufacturing processes?